HomeBUSINESS
BUSINESS

Japan Approves 1st Rituxan Biosimilar from Sandoz
(Sep.28.2017)

The Ministry of Health, Labor and Welfare (MHLW) on September 27 approved Japan’s first Rituxan (rituximab) biosimilar by Sandoz, which will be marketed and distributed through its partner Kyowa Hakko Kirin ...
(LOG IN FOR FULL STORY)

News Calendar